List of Tables
    Table 1. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Opportunities & Trends in Global Market
    Table 2. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Drivers in Global Market
    Table 3. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Restraints in Global Market
    Table 4. Key Players of Paclitaxel and Its Analogue in Anticarcinoma Drugs in Global Market
    Table 5. Top Paclitaxel and Its Analogue in Anticarcinoma Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Type
    Table 9. List of Global Tier 1 Paclitaxel and Its Analogue in Anticarcinoma Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Paclitaxel and Its Analogue in Anticarcinoma Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Bristol-Myers Squibb Corporate Summary
    Table 31. Bristol-Myers Squibb Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 32. Bristol-Myers Squibb Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Celgene Corporation Corporate Summary
    Table 34. Celgene Corporation Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 35. Celgene Corporation Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Hospira Corporate Summary
    Table 37. Hospira Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 38. Hospira Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Biological E. Corporate Summary
    Table 40. Biological E. Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 41. Biological E. Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Taj Accura Corporate Summary
    Table 43. Taj Accura Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 44. Taj Accura Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Khandelwal Laboratories Corporate Summary
    Table 46. Khandelwal Laboratories Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 47. Khandelwal Laboratories Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Luye Pharma Corporate Summary
    Table 49. Luye Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 50. Luye Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Beijing Youcare Corporate Summary
    Table 52. Beijing Youcare Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 53. Beijing Youcare Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Beijing Union Corporate Summary
    Table 55. Beijing Union Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 56. Beijing Union Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Haiyao Corporate Summary
    Table 58. Haiyao Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 59. Haiyao Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. Chuntch Corporate Summary
    Table 61. Chuntch Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 62. Chuntch Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 63. Hengrui Medicine Corporate Summary
    Table 64. Hengrui Medicine Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 65. Hengrui Medicine Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 66. Sanofi Corporate Summary
    Table 67. Sanofi Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 68. Sanofi Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 69. Qilu Pharma Corporate Summary
    Table 70. Qilu Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 71. Qilu Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 72. Shenzhen Main Luck Pharma Corporate Summary
    Table 73. Shenzhen Main Luck Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 74. Shenzhen Main Luck Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 75. Jiangsu Aosaikang Pharma Corporate Summary
    Table 76. Jiangsu Aosaikang Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 77. Jiangsu Aosaikang Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 78. CSPC Pharmaceutical Corporate Summary
    Table 79. CSPC Pharmaceutical Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 80. CSPC Pharmaceutical Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
    Table 81. Aosaikang Pharm Corporate Summary
    Table 82. Aosaikang Pharm Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Offerings
    Table 83. Aosaikang Pharm Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Paclitaxel and Its Analogue in Anticarcinoma Drugs Segment by Type in 2021
    Figure 2. Paclitaxel and Its Analogue in Anticarcinoma Drugs Segment by Application in 2021
    Figure 3. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue in 2021
    Figure 8. By Type - Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share, 2017-2028
    Figure 12. US Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share, 2017-2028
    Figure 24. China Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Bristol-Myers Squibb Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Celgene Corporation Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Hospira Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Biological E. Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Taj Accura Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Khandelwal Laboratories Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Luye Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Beijing Youcare Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Beijing Union Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Haiyao Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Chuntch Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Hengrui Medicine Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Sanofi Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Qilu Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Shenzhen Main Luck Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Jiangsu Aosaikang Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. CSPC Pharmaceutical Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Aosaikang Pharm Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)